Related by context. Frequent words. (Click for all words.) 63 Celera Diagnostics 57 Regulus Therapeutics 56 Including discontinued operations 56 Idera Pharmaceuticals 54 CFFT 54 Symyx Technologies 53 PTOI 53 Genitope Corporation 53 Nasdaq ISIS 53 Pharmion Corporation 53 Tekmira Pharmaceuticals Corporation 52 Nasdaq VRTX 52 Sirna Therapeutics 52 Celera Corporation 51 Immunogen 51 Perlegen 51 No. #R 51 Avidia 51 Celera Genomics 51 XOMA Ltd. 51 Ore Pharmaceuticals 51 Codon Devices 51 Abbott Molecular 51 Caprion 51 EPIX Pharmaceuticals 51 Applera 51 Halozyme Therapeutics 51 MDS Analytical Technologies 51 Inc. NASDAQ ILMN 51 Sangamo BioSciences Inc. 51 Inc. NASDAQ CLDA 51 DNA Sequencing 51 Celladon 50 Restructuring Charges 50 Biomarker Discovery 50 Interest Income Expense 50 Adjusted Diluted EPS 50 Ingenuity Systems 50 AVEO Pharmaceuticals Inc. 50 Acadia Pharmaceuticals 50 Xenogen 50 Protein Design 50 Altus Pharmaceuticals 50 Neurogen Corporation 50 Icoria 50 Alnylam Pharmaceuticals Inc. 50 Celera 50 Alnylam Pharmaceuticals 50 Idenix Pharmaceuticals 50 Allovectin 7 R 49 YTD Fiscal 49 SGX Pharmaceuticals 49 Response Genetics Inc. 49 CoGenesys 49 Enzo Biochem Inc. 49 marketable securities totaled 49 Pharsight Corporation 49 Laureate Pharma 49 Nano Terra 49 Gene Logic 49 TorreyPines Therapeutics 49 Molecular diagnostics 49 Array BioPharma 49 Osteocel 49 Normalized FFO 49 Ambrx 49 Cell Biosciences 49 Response Genetics 49 Ciphergen 49 Enzon Pharmaceuticals 49 ridaforolimus 49 SciClone Pharmaceuticals Inc. 49 Gen Probe Incorporated 49 Titan Pharmaceuticals 49 Unaudited Condensed Consolidated 49 Segment Profit 49 income allocable 49 Ardea Biosciences Inc. 49 Genaissance 49 Furiex 49 Asentar 49 Predix 49 Adjusted pro forma 48 BioMarin Pharmaceutical 48 XTENT 48 CuraGen Corporation 48 Ceregene 48 c Represents 48 Maxygen 48 Million Financing 48 Dynogen 48 PDL BioPharma 48 Interest Expense Net 48 CoTherix 48 Tolerx 48 Epimmune 48 Transkaryotic Therapies Inc. 48 - OperatiMcGrath RentCorp 48 Kyowa Hakko Kirin 48 Anacor 48 Belinostat